SchumacherFFlorianSSchnapperAMonienBHMewisISchreinerMet al
Eli Lilly completed a 48 week phase 2 trial on a selective amylin agonist, eloralintide
A key feature of this approach is its ability to harness the regenerative potential of stem cells, with the goal of supporting both health and beauty from within
Here is what peer-reviewed science published through 2025 actually shows: Five randomised controlled trials on oral glutathione (250500mg/day) have shown significant reductions in the melanin index compared to placebo, with excellent safety profiles
Are you interested in Growth Factors and skincare
CrossRef Plant-Derived Lactobacillus paracasei IJH-SONE68 Improves the Gut Microbiota Associated with Hepatic Disorders: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial Narandalai Danshiitsoodol, Masafumi Noda, Keishi Kanno, Tomoyuki Uchida, Masanori Sugiyama Nutrients.2022